PAPER Olin JT, Aarsland D, Meng X
SEARCH RESULTS
331710 RESULTS
PAPER Kester MI, Boelaarts L, Bouwman FH, Vogels RL, Groot ER, van Elk EJ, Blankenstein MA, van der Flier WM, Scheltens P
Diagnostic impact of CSF biomarkers in a local hospital memory clinic.
Dement Geriatr Cogn Disord. 2010;29(6):491-7. Epub 2010 Jun 3 PubMed: 20523047PAPER Barekatain M, Walterfang M, Behdad M, Tavakkoli M, Mahvari J, Maracy MR, Velakoulis D
Validity and reliability of the Persian language version of the neuropsychiatry unit cognitive assessment tool.
Dement Geriatr Cogn Disord. 2010 Jul;29(6):516-22. PubMed: 20523051PAPER Beecham GW, Naj AC, Gilbert JR, Haines JL, Buxbaum JD, Pericak-Vance MA
PCDH11X variation is not associated with late-onset Alzheimer disease susceptibility.
Psychiatr Genet. 2010 Dec;20(6):321-4. PubMed: 20523261PAPER Kubová Z, Kremlácek J, Valis M, Langrová J, Szanyi J, Vít F, Kuba M
Visual evoked potentials to pattern, motion and cognitive stimuli in Alzheimer's disease.
Doc Ophthalmol. 2010 Aug;121(1):37-49. PubMed: 20524039PAPER Chen S, Seeman P, Liu F
Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia.
Synapse. 2011 Feb;65(2):119-24. PubMed: 20524177PAPER Stemmler TL, Lesuisse E, Pain D, Dancis A
Frataxin and mitochondrial FeS cluster biogenesis.
J Biol Chem. 2010 Aug 27;285(35):26737-43. PubMed: 20522547PAPER Hirth F
Drosophila melanogaster in the study of human neurodegeneration.
CNS Neurol Disord Drug Targets. 2010 Aug;9(4):504-23. PubMed: 20522007PAPER Fernández-Checa JC, Fernández A, Morales A, Marí M, García-Ruiz C, Colell A
Oxidative stress and altered mitochondrial function in neurodegenerative diseases: lessons from mouse models.
CNS Neurol Disord Drug Targets. 2010 Aug;9(4):439-54. PubMed: 20522012PAPER Pérez-De La Cruz V, Carrillo-Mora P, Santamaría A
Huntington's disease and mitochondrial alterations: emphasis on experimental models.
J Bioenerg Biomembr. 2010 Jun;42(3):207-15. PubMed: 20524050PAPER Kasuga K, Tokutake T, Ishikawa A, Uchiyama T, Tokuda T, Onodera O, Nishizawa M, Ikeuchi T
Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease.
J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):608-10. PubMed: 20522869PAPER Jinwal UK, Koren J, O'Leary JC, Jones JR, Abisambra JF, Dickey CA
Hsp70 ATPase Modulators as Therapeutics for Alzheimer's and other Neurodegenerative Diseases.
Mol Cell Pharmacol. 2010 Jan 1;2(2):43-46. PubMed: 20523917PAPER Skaper SD
Transgenic animal models of neurodegenerative diseases.
CNS Neurol Disord Drug Targets. 2010 Aug;9(4):384-5. PubMed: 20522006PAPER Peviani M, Caron I, Pizzasegola C, Gensano F, Tortarolo M, Bendotti C
Unraveling the complexity of amyotrophic lateral sclerosis: recent advances from the transgenic mutant SOD1 mice.
CNS Neurol Disord Drug Targets. 2010 Aug;9(4):491-503. PubMed: 20522008PAPER Skaper SD, Giusti P
Transgenic mouse models of Parkinson's disease and Huntington's disease.
CNS Neurol Disord Drug Targets. 2010 Aug;9(4):455-70. PubMed: 20522011Current Filters
No filters selected